BACKGROUND AND OBJECTIVES: Circulating troponin T levels are frequently elevated in patients undergoing long-term dialysis. The pathophysiology underlying these elevations is controversial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In 70 prevalent hemodialysis (HD) patients, HD-induced myocardial stunning was assessed echocardiographically at baseline and after 12 months. Nineteen patients were not available for the follow-up analysis. The extent to which predialysis troponin T was associated with the occurrence of HD-induced myocardial stunning was assessed as the primary endpoint. RESULTS: The median troponin T level in this hemodialysis cohort was 0.06 ng/ml (interquartile range, 0.02-0.10). At baseline, 64% of patients experienced myocardial stunning. These patients showed significantly higher troponin T levels than patients without stunning (0.08 ng/ml [0.05-0.12] versus 0.02 ng/ml [0.01-0.05]). Troponin T levels were significantly correlated to measures of myocardial stunning severity (number of affected segments: r=0.42; change in ejection fraction from beginning of dialysis to end of dialysis: r=-0.45). In receiver-operating characteristic analyses, predialytic troponin T achieved an area under the curve of 0.82 for the detection of myocardial stunning. In multivariable analysis, only ultrafiltration volume (odds ratio, 4.38 for every additional liter) and troponin T (odds ratio, 9.33 for every additional 0.1 ng/ml) were independently associated with myocardial stunning. After 12 months, nine patients had newly developed myocardial stunning and showed a significant increase in troponin T over baseline (0.03 ng/ml at baseline versus 0.05 ng/ml at year 1). CONCLUSIONS: Troponin T levels in HD patients are associated with the presence and severity of HD-induced myocardial stunning.
BACKGROUND AND OBJECTIVES: Circulating troponin T levels are frequently elevated in patients undergoing long-term dialysis. The pathophysiology underlying these elevations is controversial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In 70 prevalent hemodialysis (HD) patients, HD-induced myocardial stunning was assessed echocardiographically at baseline and after 12 months. Nineteen patients were not available for the follow-up analysis. The extent to which predialysis troponin T was associated with the occurrence of HD-induced myocardial stunning was assessed as the primary endpoint. RESULTS: The median troponin T level in this hemodialysis cohort was 0.06 ng/ml (interquartile range, 0.02-0.10). At baseline, 64% of patients experienced myocardial stunning. These patients showed significantly higher troponin T levels than patients without stunning (0.08 ng/ml [0.05-0.12] versus 0.02 ng/ml [0.01-0.05]). Troponin T levels were significantly correlated to measures of myocardial stunning severity (number of affected segments: r=0.42; change in ejection fraction from beginning of dialysis to end of dialysis: r=-0.45). In receiver-operating characteristic analyses, predialytic troponin T achieved an area under the curve of 0.82 for the detection of myocardial stunning. In multivariable analysis, only ultrafiltration volume (odds ratio, 4.38 for every additional liter) and troponin T (odds ratio, 9.33 for every additional 0.1 ng/ml) were independently associated with myocardial stunning. After 12 months, nine patients had newly developed myocardial stunning and showed a significant increase in troponin T over baseline (0.03 ng/ml at baseline versus 0.05 ng/ml at year 1). CONCLUSIONS: Troponin T levels in HDpatients are associated with the presence and severity of HD-induced myocardial stunning.
Authors: D A Morrow; E M Antman; M Tanasijevic; N Rifai; J A de Lemos; C H McCabe; C P Cannon; E Braunwald Journal: J Am Coll Cardiol Date: 2000-11-15 Impact factor: 24.094
Authors: Helen J Jefferies; Bhupinder Virk; Brigitte Schiller; John Moran; Christopher W McIntyre Journal: Clin J Am Soc Nephrol Date: 2011-05-19 Impact factor: 8.237
Authors: J Ishii; M Nomura; T Okuma; T Minagawa; H Naruse; Y Mori; T Ishikawa; H Kurokawa; T Hirano; T Kondo; Y Nagamura; K Ezaki; H Hishida Journal: Clin Chim Acta Date: 2001-10 Impact factor: 3.786
Authors: Johan G Bosch; Steven C Mitchell; Boudewijn P F Lelieveldt; Francisca Nijland; Otto Kamp; Milan Sonka; Johan H C Reiber Journal: IEEE Trans Med Imaging Date: 2002-11 Impact factor: 10.048
Authors: Christopher deFilippi; Steven Wasserman; Salvatore Rosanio; Eric Tiblier; Heidi Sperger; Monica Tocchi; Robert Christenson; Barry Uretsky; Mathew Smiley; Judith Gold; Henry Muniz; John Badalamenti; Charles Herzog; William Henrich Journal: JAMA Date: 2003-07-16 Impact factor: 56.272
Authors: Nicholas M Selby; James O Burton; Lindsay J Chesterton; Christopher W McIntyre Journal: Clin J Am Soc Nephrol Date: 2006-10-11 Impact factor: 8.237
Authors: Kelvin C W Leung; Robert R Quinn; Pietro Ravani; Henry Duff; Jennifer M MacRae Journal: Clin J Am Soc Nephrol Date: 2017-10-10 Impact factor: 8.237
Authors: Ruth F Dubin; Alexis L Beatty; John R Teerlink; Nelson B Schiller; Ann F Bolger; Dean Alokozai; Carmen A Peralta; Kirsten L Johansen Journal: Hemodial Int Date: 2013-11-14 Impact factor: 1.812
Authors: LaTonya J Hickson; Andrew D Rule; Kenneth R Butler; Gary L Schwartz; Allan S Jaffe; Adam C Bartley; Thomas H Mosley; Stephen T Turner Journal: Mayo Clin Proc Date: 2015-10-19 Impact factor: 7.616
Authors: Dong Ling Tong; David J Boocock; Gopal Krishna R Dhondalay; Christophe Lemetre; Graham R Ball Journal: PLoS One Date: 2014-07-15 Impact factor: 3.240
Authors: Joanna Leigh Dunlop; Alain Charles Vandal; Janak Rashme de Zoysa; Ruvin Sampath Gabriel; Lukas Mathias Gerber; Imad Adbi Haloob; Christopher John Hood; John Hamilton Irvine; Philip James Matheson; David Owen Ross McGregor; Kannaiyan Samuel Rabindranath; John Benedict William Schollum; David John Semple; Mark Roger Marshall Journal: BMC Nephrol Date: 2014-07-21 Impact factor: 2.388
Authors: Sunna Snaedal; Peter Bárány; Sigrún H Lund; Abdul R Qureshi; Olof Heimbürger; Peter Stenvinkel; Christian Löwbeer; Karolina Szummer Journal: Clin Kidney J Date: 2020-12-12